Gender-specific Rhabdomyolysis risk in Alzheimer’s disease patients receiving memantine: a pharmacovigilance study

Gender-specific Rhabdomyolysis risk in Alzheimer’s disease patients receiving memantine: a pharmacovigilance study

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.

Dades bibliogràfiques
Autor principal:	Tabassum, Nadira
Altres autors:	Yasmin, Hasina
Format:	Thesis
Idioma:	English
Publicat:	Brac University 2024
Matèries:	Pharmacovigilance Alzheimer disease Dementia Rhabdomyolysis Alzheimer's disease
Accés en línia:	http://hdl.handle.net/10361/22868

Ítems similars

Signal detection of Rhabdomyolysis and death for galantamine: a pharmacovigilance study
per: Karmaker, Swastika
Publicat: (2024)

Signal detection of rhabdomyolysis and death for rivastigmine: a pharmacovigilance study
per: Mahee, Sadique Abdal
Publicat: (2024)

A pharmacovigilance study to determine risk of mortality in male and female patients with Alzheimer's disease using Rivastigmine
per: Shehab, Habibul Mohsin
Publicat: (2024)

A pharmacovigilance study on Donepezil: signal detection of rhabdomyolysis and death
per: Jahan, Nusrat
Publicat: (2023)

A pharmacovigilance study on Memantine: signal detection of Rhabdomyolysis and death
per: Bakar, Osama Bin Abu
Publicat: (2024)

Comprehensive review on importance, challenges and future prospects of nanotechnology and combination therapy for Alzheimer’s disease
per: Ishrat, Nowshin
Publicat: (2024)

Efficacy of Rivastigmine in Alzheimer’s disease- A structured seview
per: Alim, Abdul
Publicat: (2023)

Knowledge of Alzheimer’s disease and its relationship with attitude towards genetic testing for the disease: a survey of the general public in Bangladesh
per: Chowdhury, Sariya Uzrat
Publicat: (2022)

Role of protein’s and future treatment options for Alzheimer’s Disease
per: Islam, Md. Irfath
Publicat: (2023)

Review on: Contribution of nutrients to retard the progression of Alzheimer’s disease
per: Saha, Bithi Rani
Publicat: (2023)

Alzheimer's disease and marriage : an intimate account /
per: Wright, Lore K.
Publicat: (1993)

Gene editing for neurodegenerative diseases-A review
per: Sharna, Anika Islam
Publicat: (2023)

Progress of finding latent therapeutic activity of vaccine for Alzheimer’s disease
per: Hassan, Md. Muhtaz
Publicat: (2020)

Emerging therapies of Alzheimer’s disease: a comprehensive review
per: Tasin, Md Abtahi
Publicat: (2023)

Biomarkers of Alzheimer’s disease: a hope for early diagnosis
per: Aziz, Farhin
Publicat: (2019)

Bio-similar drug development and accessible drugs in the market for the treatment of Alzheimer's Disease: Current status
per: Tamanna, Mst. Taskia
Publicat: (2023)

Prospective detection methods for Tau protein: an important biomarker for Alzheimer’s disease
per: Afra, Sumaiya
Publicat: (2022)

Glymphatic system: a pathway for managing endogenous metabolites in CNS
per: Tasneem, Sadia
Publicat: (2021)

Marine compounds in the treatment of Alzheimer’s disease
per: Parveen, Sanjana
Publicat: (2022)

Application of microRNA (miRNA) in Alzheimer’s Disease (AD)
per: Halim, Rabea
Publicat: (2022)

An ambient assisted living system for Alzheimer’s patients
per: Abedin, Minhajul, et al.
Publicat: (2023)

Exploring Alzheimer's disease prediction with XAI in various neural network models
per: Rahman, Quazi Ashikur, et al.
Publicat: (2022)

Exploring the role of programmed cell death protein 1 in alzheimer’s disease associated autoimmunity
per: Aana, Afsara Sumon
Publicat: (2021)

Epigenetic dysregulation in neurodegenerative diseases and potential treatment
per: Mostofa, Golam
Publicat: (2022)

A review on adult neurogenesis in Alzheimer’s disease
per: Akter, Moriam
Publicat: (2022)

Potential treatments for epigenetic dysregulation in neurological diseases
per: Zaman, Rubaiyat
Publicat: (2024)

Federated GAN based biomedical image augmentation and classification for Alzheimer’s disease
per: Roy, Aditya, et al.
Publicat: (2023)

Mini-mental state examination in non-hospitalized post covid patients to identify cognitive decline
per: Tanjum, Silvia
Publicat: (2024)

Investigating the link between Cardiovascular diseases and neurodegenerative disorders
per: Dey, Manashi
Publicat: (2024)

A review of comparison on efficacy, safety and cost effectiveness of cholinesterase inhibitors, NMDA antagonists and combination therapy in the treatment of Alzheimer’s disease
per: Haque, Mushfiqul
Publicat: (2019)

Role of circular RNA in neurological disease
per: Salsabil, Labiba
Publicat: (2024)

An efficient deep learning approach for detecting Alzheimer’s disease using brain images
per: Sani, Mehedi Hasan, et al.
Publicat: (2022)

Status of cognitive decline in post covid-19 Bangladeshi patients
per: Bapan, Pranta Saha
Publicat: (2024)

Design and evaluation of convolutional neural network for detection of Alzheimer’s disease using MRI data
per: Mahbub, Riasat, et al.
Publicat: (2022)

Anti-alzheimer and antioxidant activity of celastrus paniculatus seed
per: Alam, Badrul, et al.
Publicat: (2016)

Skeleton /
per: Parkin, Peter

Detection of alzheimer's disease using deep learning
per: Hasan, Mahmudul, et al.
Publicat: (2021)

A review on interrelation among post-authorisation study, regulatory action and pharmacogenetics in pharmacovigilance
per: Nusrat, Tanzina
Publicat: (2019)

Early prediction of Alzheimer's disease using convolutional neural network
per: Abed, Mahjabeen Tamanna, et al.
Publicat: (2020)

Antihypertensive drugs and risk of cancer: A pharmacovigilance study
per: Rahman, Ahadina
Publicat: (2018)